RCC

Expert-driven insights on renal cell carcinoma, highlighting evolving treatment strategies including immunotherapy and targeted therapies across disease settings. Focuses on treatment sequencing, biomarker integration, and emerging clinical data to support personalized, evidence-based care.

Ep. 5: Optimizing Sequential Therapy in Advanced RCC

Bradley McGregor, MD, Ulka Vaishampayan, MBBS, David Braun, MD, PhD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Ep. 4: Second-Line RCC Management: Tolerability, Comorbidities, and Long-Term Planning

Ulka Vaishampayan, MBBS, Bradley McGregor, MD, David Braun, MD, PhD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Ep. 3: Balancing Patient Goals and Efficacy in Second-Line RCC Therapy

David Braun, MD, PhD, Ulka Vaishampayan, MBBS, Bradley McGregor, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Ep. 2: VEGF TKIs in RCC: Toxicity and Tolerability

David Braun, MD, PhD, Bradley McGregor, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Ep. 1: Positioning Tivozanib in Today’s RCC Treatment Landscape

Ulka Vaishampayan, MBBS, David Braun, MD, PhD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Treating Advanced RCC After First-Line Therapy (Full Video)

David Braun, MD, PhD, Bradley McGregor, MD, Ulka Vaishampayan, MBBS, Rahul Gosain, MD, MBA, Rohit Gosain, MD